ACW 5.71% 7.4¢ actinogen medical limited

11βHSD1 inhibitor use in human disease- a systematic review and narrative synthesis

  1. 43 Posts.
    lightbulb Created with Sketch. 49
    [email protected]

    Research paper published by the Actinogen team diving into the current literature on 11BHSD1 inhibition. They describe some potential future indications for Xanamem but nothing conclusive - the science is still quite unclear on this one unfortunately.


 
watchlist Created with Sketch. Add ACW (ASX) to my watchlist
(20min delay)
Last
7.4¢
Change
0.004(5.71%)
Mkt cap ! $199.2M
Open High Low Value Volume
7.1¢ 7.4¢ 7.1¢ $182.2K 2.510M

Buyers (Bids)

No. Vol. Price($)
2 437259 7.2¢
 

Sellers (Offers)

Price($) Vol. No.
7.4¢ 289428 3
View Market Depth
Last trade - 16.10pm 11/07/2024 (20 minute delay) ?
ACW (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.